patients should confirm with their clinician and pharmacy that the sourcing is compliant
One paper in March this year concluded that there was significant heterogeneity in the effects of GLP-1RAs across different cancer types. Theres some evidence they might protect against colorectal, prostate, and liver cancer, but may increase the risk of thyroid cancer
GIP enhances insulin secretion in a glucose-dependent manner, improves fat tissue metabolism, and may contribute to appetite regulation through mechanisms still being fully characterized
Compounded versions, on the other hand, may be supplied in vials, requiring manual measurement and injection
after all, a person can be hypersensitive to anything, even things that occur naturally in the body